Cowen RL - Search Results

1

Radiation enhances the therapeutic effect of Banoxantrone in hypoxic tumour cells with elevated levels of nitric oxide synthase.

Mehibel M, Singh S, Cowen RL, Williams KJ, Stratford IJ. Mehibel M, et al. Among authors: cowen rl. Oncol Rep. 2016 Apr;35(4):1925-32. doi: 10.3892/or.2016.4555. Epub 2016 Jan 13. Oncol Rep. 2016. PMID: 26782976 Free PMC article.

2

Combining bioreductive drugs and radiation for the treatment of solid tumors.

Stratford IJ, Williams KJ, Cowen RL, Jaffar M. Stratford IJ, et al. Among authors: cowen rl. Semin Radiat Oncol. 2003 Jan;13(1):42-52. doi: 10.1053/srao.2003.50008. Semin Radiat Oncol. 2003. PMID: 12520463 Review.

3

Dual responsive promoters to target therapeutic gene expression to radiation-resistant hypoxic tumor cells.

Chadderton N, Cowen RL, Sheppard FC, Robinson S, Greco O, Scott SD, Stratford IJ, Patterson AV, Williams KJ. Chadderton N, et al. Among authors: cowen rl. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):213-22. doi: 10.1016/j.ijrobp.2005.01.031. Int J Radiat Oncol Biol Phys. 2005. PMID: 15850924

4

iNOS as a therapeutic target for treatment of human tumors.

Fitzpatrick B, Mehibel M, Cowen RL, Stratford IJ. Fitzpatrick B, et al. Among authors: cowen rl. Nitric Oxide. 2008 Sep;19(2):217-24. doi: 10.1016/j.niox.2008.05.001. Epub 2008 May 13. Nitric Oxide. 2008. PMID: 18515106 Review.

5

Effects of cytokine-induced macrophages on the response of tumor cells to banoxantrone (AQ4N).

Mehibel M, Singh S, Chinje EC, Cowen RL, Stratford IJ. Mehibel M, et al. Among authors: cowen rl. Mol Cancer Ther. 2009 May;8(5):1261-9. doi: 10.1158/1535-7163.MCT-08-0927. Epub 2009 May 12. Mol Cancer Ther. 2009. PMID: 19435866

6

The impact of intracellular generation of nitric oxide on the radiation response of human tumor cells.

Singh S, Cowen RL, Chinje EC, Stratford IJ. Singh S, et al. Among authors: cowen rl. Radiat Res. 2009 May;171(5):572-80. doi: 10.1667/RR1640.1. Radiat Res. 2009. PMID: 19580492

7

Hypoxia and oxidative stress. Tumour hypoxia--therapeutic considerations.

Williams KJ, Cowen RL, Stratford IJ. Williams KJ, et al. Among authors: cowen rl. Breast Cancer Res. 2001;3(5):328-31. doi: 10.1186/bcr316. Epub 2001 Aug 7. Breast Cancer Res. 2001. PMID: 11597323 Free PMC article. Review.

8

Antiangiogenic, bioreductive and gene therapy approaches to the treatment of hypoxic tumours.

McNally VA, Patterson AV, Williams KJ, Cowen RL, Stratford IJ, Jaffar M. McNally VA, et al. Among authors: cowen rl. Curr Pharm Des. 2002;8(15):1319-33. doi: 10.2174/1381612023394548. Curr Pharm Des. 2002. PMID: 12052210 Review.

9

Non-nuclear localized human NOSII enhances the bioactivation and toxicity of tirapazamine (SR4233) in vitro.

Chinje EC, Cowen RL, Feng J, Sharma SP, Wind NS, Harris AL, Stratford IJ. Chinje EC, et al. Among authors: cowen rl. Mol Pharmacol. 2003 Jun;63(6):1248-55. doi: 10.1124/mol.63.6.1248. Mol Pharmacol. 2003. PMID: 12761334

10

Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts.

Cowen RL, Patterson AV, Telfer BA, Airley RE, Hobbs S, Phillips RM, Jaffar M, Stratford IJ, Williams KJ. Cowen RL, et al. Mol Cancer Ther. 2003 Sep;2(9):901-9. Mol Cancer Ther. 2003. PMID: 14555709

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters